Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Medecine Sciences : M/S|January 7, 2020
[The biology of PD1 and CTLA-4 as immunotherapeutic targets and the issue of biomarkers]Marie-Caroline Dieu-Nosjean, Christophe CauxCancer Immunology Research|July 8, 2022
Direct T-cell Presentation by cDC1: The Key Feature for Cancer Vaccine Success?Margaux Hubert, Christophe Caux, Jenny Valladeau-GuilemondCancer Research|October 8, 2009
Differences in tumor regulatory T-cell localization and activation status impact patient outcomeChristine Ménétrier-Caux, Michael Gobert, Christophe CauxBulletin Du Cancer|January 19, 2024
[Cell therapy in all its forms]Aurore Dougé, Christophe Caux, Jacques-Olivier BayNovartis Foundation Symposium|March 19, 2004
In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunityAlain P Vicari, Béatrice Vanbervliet, Catherine Massacrier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2014
Intratumoral immunization: a new paradigm for cancer therapyAurélien Marabelle, Holbrook Kohrt, Christophe Caux, et al.Mutagenesis|February 18, 2015
Paradigm shift in oncology: targeting the immune system rather than cancer cellsTala Shekarian, Sandrine Valsesia-Wittmann, Christophe Caux, et al.Cancer Research|April 19, 2005
Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejectionCristiana Guiducci, Alain P Vicari, Sabina Sangaletti, et al.Oncoimmunology|December 8, 2018
MDR1 in immunity: friend or foe?Marion Bossennec, Anthony Di Roio, Christophe Caux, et al.Bulletin Du Cancer|May 7, 2023
[Tertiary lymphoid structures in cancer: From biology to therapeutic guides]Stanislas Quesada, Coriolan Lebreton, Christophe Caux, et al.Pageof 15